Title: 2015 ACVIM Forum Research Abstract Program Document date: 2015_5_27
ID: 3pnuj5ru_297
Snippet: The primary objective of this study was to evaluate the efficacy and safety of a combination of a short-acting GLP-1 mimetic (Exenatide) with glargine insulin (Protocol A) compared to glargine with a placebo (Protocol B) for the treatment of DM in overweight cats. The effect of treatment protocol A versus B on serum concentrations of specific hormones that play a role in glycemic regulation (insulin and glucagon) or in altering insulin sensitivit.....
Document: The primary objective of this study was to evaluate the efficacy and safety of a combination of a short-acting GLP-1 mimetic (Exenatide) with glargine insulin (Protocol A) compared to glargine with a placebo (Protocol B) for the treatment of DM in overweight cats. The effect of treatment protocol A versus B on serum concentrations of specific hormones that play a role in glycemic regulation (insulin and glucagon) or in altering insulin sensitivity and resistance (leptin and adiponectin) was also determined.
Search related documents:
Co phrase search for related documents- DM treatment and insulin sensitivity: 1
- DM treatment and safety efficacy: 1
- glargine insulin and glucagon insulin: 1
- glargine insulin and glycemic regulation: 1
- glargine insulin and insulin sensitivity: 1
- glargine insulin and Protocol glargine insulin: 1
- glargine insulin and safety efficacy: 1, 2, 3, 4
- glargine insulin and treatment protocol: 1
- glucagon insulin and insulin sensitivity: 1, 2, 3, 4, 5
- glucagon insulin and safety efficacy: 1, 2
- glycemic regulation and insulin sensitivity: 1
- glycemic regulation and Protocol glargine insulin: 1
- glycemic regulation and treatment protocol: 1
Co phrase search for related documents, hyperlinks ordered by date